AGEM unites the research at the Amsterdam UMC involved at the intersection of nutrition, microbiology, digestion, endocrinology and metabolism and aims to make an important contribution to improve gastrointestinal, endocrine and metabolic health and reduce the burden of diseases such as colorectal cancer (CRC), inflammatory bowel disease (IBD), diabetes mellitus (DM) and phenylketonuria (PKU). 
Fueling the body’s machinery

AGEM mission

The AGEM mission is: ‘to perform research that promotes healthy nutrition and metabolism, prevents or cures gastrointestinal, endocrine and metabolic disease and improves the outcomes of our patients.’

The researchers in the AGEM institute will closely collaborate with internal and external academic and commercial parties to perform research with a true impact on the current state-of-the-art. This impact is achieved at three important levels:

  • Making fundamental discoveries of the mechanisms that maintain organ homeostasis in health and the way these are deregulated in disease.
  • Translating the revolutionary advances made in molecular biology to modern medicine.
  • Performing clinical research that truly improves our current algorithms for disease prevention and cure.

AGEM vision

The AGEM vision and 2023 goal is: ‘to add value to our research by joining the Amsterdam UMC research in gastrointestinal, endocrine and metabolic health and disease into a single research organization with 4 research programs.’

Within these research programs we aim to further develop strong research lines that belong to the top of the international basic, translational and clinical research in our field by contributing

Cogs in the body